Sens. Baucus, Grassley Head Down Diverging Paths On Drug Price Negotiation As House Clears Pricing Measure
This article was originally published in The Pink Sheet Daily
Executive Summary
Baucus now favors repealing the noninterference clause but proceeding “cautiously.” Spotlight shifts to the Senate after the House clears HR 4.